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 COST-EFFECTIVENESS 
IN ANIMAL HEALTH 
 An Ethical Analysis 
 Govind  Persad 
 Introduction 
 Many national health systems use cost-effectiveness information as part of determining which 
human health interventions to provide. The two most prominent cost-effectiveness metrics are 
 quality-adjusted and disability-adjusted life-years (QALYs and DALYs, respectively), which typically 
are based on surveys of individuals’ subjective experience of health setbacks. The ethicist Toby Ord 
has described consideration of cost-effectiveness as a “moral imperative,” because replacing less cost-
effective treatments with more cost-effective ones can vastly increase the benefi ts a health system 
produces ( Ord 2013 ). But other ethicists have criticized the use of cost-effectiveness information in 
priority-setting for giving no weight to distributional issues or making it more diffi cult for elderly 
and disabled individuals to receive health care interventions ( Brock 2003 ). Some have attempted to 
reconcile these perspectives ( John et al. 2017). 
 There is no similarly systematic discussion of the ethics of using cost-effectiveness information to 
set animal health priorities. 1 This may once have refl ected the diffi culty of assessing animals’ quality 
of life. But the increasing availability of quality-of-life information about animals indicates the value 
of parallel conceptual work on the ethics of using cost-effectiveness methods in animal health. One 
recent commentator observes that “[s]urprisingly, utility indices are not yet widely used in veterinary 
decision science or in veterinary practices,” even though “quantifi cation of disease burden could be 
very useful for decision making, priority setting and treatment comparisons in animal health care or 
simply to get an impression of the [quality of life] of the animal” ( Pesie 2012 ). 
 This chapter evaluates the ethical issues that using cost-effectiveness considerations to set animal 
health priorities might present.in. Ultimately, its conclusions are cautiously optimistic. While using 
cost-effectiveness calculations in animal health is not without ethical pitfalls, these calculations offer a 
pathway toward more rigorous priority-setting efforts that allow money spent on animal well-being 
to do more good. Although assessing quality of life for animals may be more challenging than in 
humans, implementing prioritization based on cost-effectiveness is less ethically fraught. 
 In the fi rst part, I review the current state of empirical measures of animal quality of life and 
consider the conceptual choices that underpin them, including philosophical disagreements about 
what quality of life amounts to and practical challenges in assessing the quality of life of creatures 
who cannot self-report their experiences using language. In the second part, I examine how ethical 
controversies presented by the use of cost-effectiveness information to set priorities for human health 
translate to the animal health context, such as confl icts between cost-effectiveness and individual 
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rights. I also consider distinctive ethical challenges that the animal health context presents, in par-
ticular the problem of making cross-species comparisons of quality of life. In the third part, I consider 
different ways in which cost-effectiveness assessments could be used to set priorities and argue that 
doing so is both possible and desirable. 
 Measuring Cost-Effectiveness in Animal Health 
 Determining the cost-effectiveness of a health intervention involves assessing two different aspects 
of an intervention: (1) its cost and (2) its effects on length and quality of life. These two assessments 
are combined to produce a cost-effectiveness ratio. For instance, a course of cetuximab, a cancer 
treatment, costs US$80,000 and improves overall survival in humans by 1.2 months, producing a 
cost-effectiveness ratio of more than $800,000 per life-year ( Fojo and Grady 2009 ). 
 Assessing the cost of animal health interventions is no more diffi cult than assessing the cost of 
similar interventions that improve human health. Assessments of the cost of veterinary medications 
and other animal health interventions are already frequently conducted as part of cost-effectiveness 
analyses of zoonotic diseases that affect human health ( Schurer et al. 2015 ). Such assessments are also 
used in cost–benefi t analyses that compare the cost of interventions that improve livestock health 
to the economic benefi ts ranchers derive from healthier livestock ( Duarte et al. 2015 ). Likewise, the 
limitations that exist when assessing costs in human health—including the fact that sticker prices 
may not refl ect costs from a societal perspective and that costs themselves are frequently refl ective of 
societal determinations rather than being entirely independent of those determinations—apply to 
animal health ( Persad 2016 ). 
 Cost-effectiveness analyses of zoonotic diseases, however, often entirely ignore how these diseases—
and interventions to cure them—affect animals’ quality of life. For example, echinococcosis, a 
zoonotic disease caused by a parasitic worm, can lead to serious illnesses not only in humans but also 
in host animals like sheep, dogs, and horses ( Schurer et al. 2015 ). Animal health benefi ts from treating 
echinococcosis should also be part of the cost-effectiveness calculation. As Cass Sunstein has argued, 
 [o]n any plausible view, harm to animals matters, at least to some degree. This judgment 
is fi rmly refl ected in American law. At the national level, the [Endangered Species Act] is 
complemented by the Animal Welfare Act, which is designed to protect a wide range of 
animals against suffering and premature death. Every state attempts to accomplish the same 
goal through anticruelty laws. 
 ( Hsiung and Sunstein 2006 : 1695) 
 It would be at least  prima facie inconsistent with our willingness to spend money protecting the wel-
fare of laboratory and farm animals to entirely ignore animal quality of life when considering how 
much to spend treating zoonotic diseases. More generally, if we are willing to give some weight to 
animal health, it makes sense to include animal health as an outcome in a cost-effectiveness analysis. 
 In order for cost-effectiveness analysis to incorporate both the costs and the health benefi ts of 
animal health interventions, we need an effective way of measuring how these interventions affect 
animal health. The most common metric for assessing the human health impact of a given interven-
tion is the QALY. Determining QALY impact involves multiplying the number of years of life that 
the intervention provides by the quality of those years of life. In humans, comparative quality of life is 
assessed using “time trade-off ” or “standard gamble” approaches, where people are asked to say what 
risk of death they would tolerate, or how much shorter a life they would accept, in order to avoid or 
eliminate a condition that impairs quality of life. 
 Because animals typically cannot respond to surveys, other strategies must be used to assess quality 
of life. A 2000 article in the  Journal of the American Veterinary Medical Association summarizes research 
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on quality-of-life measurement in animals. The article observes that quality of life in animals is typi-
cally assessed by having proxies, such as caregivers or medical professionals, complete surveys that 
elicit their beliefs about an animal’s quality of life. The use of proxy surveys is not unique to animal 
health proxies are also used to assess quality of life for humans who are incapable of self-reporting 
their own quality of life, such as infants and those who are severely ill or disabled. Despite the limita-
tion of proxy approaches, the article asserts that “[t]he goal of measuring [quality of life] in animals 
from the perspective of the animals is not currently attainable” and that development of a proxy 
survey completed by humans offers the best chance of usefully measuring animal quality of life. Most 
of the more recent work on quality of life in animals relies on questionnaires completed by proxies 
(Belshaw et al. 2015;  Mullan 2015 ). 
 What do these questionnaires ask? The questions asked, and the underlying defi nition of quality 
of life at issue, vary widely. A recent review article asserts that few studies of quality of life actually 
offer a defi nition of quality of life (Belshaw et al. 2015). Most ask about perceived pain, and many ask 
about other topics such as function, sociability, and capacity to meet various needs. In general, these 
assessments have focused on the harms to quality of life that stem from disease, rather than consider-
ing how various capabilities might improve animals’ quality of life. 
 Conceptual work on quality-of-life assessments in animals is likewise variable. The three most 
prominent philosophical accounts of quality of life in humans are the  hedonic account, on which 
quality of life is a function of affective responses, the  desire-fulfi llment account, on which quality of 
life depends on the extent to which one’s preferences are being fulfi lled, and still others understand 
it via an  objective list account, on which quality of life constitutes possessing objectively observable 
goods or capacities ( Crisp 2016 ). Proxy questionnaires applying each of these approaches have been 
used for animal health. The hedonic approach is defended by one prominent commentator who 
contends that 
 assessment criteria, like the QOL [quality-of-life] factors they are intended to measure, have 
value only insofar as they are associated directly or indirectly with affective states. Meas-
urement criteria that are not associated with affective states are not relevant to QOL and, 
hence, play no role in assessing QOL. 
 ( McMillan 2000 ) 
 Other discussions propose using a desire-fulfi llment account in which those answering questions 
evaluate how well an animal’s preferences are being satisfi ed ( Yeates 2016 ). One questionnaire pro-
poses an objective list account, where respondents consider whether an animal enjoys various objec-
tive goods and capacities ( Wojciechowska and Hewson 2005 ;  Wojciechowska et al. 2005 ). 
 Is there any alternative to surveying humans about their perceptions of animals’ quality of life? 
Franklin McMillan asserts that “[t]he goal of measuring QOL in animals from the perspective of the 
animals is not currently attainable” ( McMillan 2000 : 1908). Despite this claim that there is no alter-
native to human-completed questionnaires, some quality-of-life assessments for laboratory animals 
infer quality of life directly from behavior rather than soliciting the perspectives of human raters. 
Some have proposed that the “Mouse Grimace Scale,” based on the idea that examining the facial 
expressions of mice could serve as an effective way of directly assessing whether mice are in pain 
( Matsumiya et al. 2012 ;  Leach et al. 2012 ). Similarly, the ability of mice to perform certain tasks, or 
their aversive behavior when faced with a stimulus, could be regarded either as indicators of qual-
ity of life or as constituents of quality of life ( Urban et al. 2011 ). The strategy of assessing quality of 
life based on direct observations of behavior could potentially be applied not only to mice but also 
to companion animals and livestock. As another example, one article proposes looking at hormonal 
and physiological changes, such as changes in heart rate or hormone concentration ( Stockman et al. 
2011 ;  Christiansen et al. 2007 ). 
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 For any of these assessment techniques, it is important to keep in view the fact that whatever is 
being measured must be matter in order to be worth measuring in the fi rst place. Some approaches 
may provide plentiful and easily accessible quantitative data, but that data may not represent any 
aspect of animals’ lives that is morally signifi cant. Even if perfect consensus cannot be reached on 
what is morally signifi cant in animal quality of life, however, the strategies presented earlier represent 
potentially effective ways of assessing quality of life in various animals. 
 Translating Current Issues in the Ethics of Cost-Effectiveness 
to Animal Ethics 
 Quality of life determinations could potentially be used for a variety of purposes, including deciding 
what sort of clinical care an animal needs, punishing those who cause unjustifi ed pain or injury to 
animals, or designing zoos, farms, and other types of spaces where animals live. My focus, however, 
is the use of quality-of-life assessments as part of priority-setting. Quality-of-life assessments are 
frequently used, in combination with costs, to generate cost-effectiveness fi gures that are then used 
to set priorities for human health. For instance, the health care system in the UK uses quality-of-life 
assessments to determine which interventions fall within a cost-effectiveness threshold ( Drummond 
and Sorenson 2009 ). They have also been proposed for use in other contexts, such as setting com-
parative priorities between health care and public health, determining which services are provided in 
markets or paid for by private insurers, and indicating which interventions should be high priorities 
for research ( Graham et al. 1998 ;  Clement et al. 2009 ;  Persad 2016 ). 
 In this section, I consider how several ethical challenges that cost-effectiveness methodologies 
face when used to set human health priorities might translate to the animal health context. These 
include the challenges of comparing quality of life across different conditions; of avoiding violations 
of rights; and of treating people with disabilities or short life expectancies fairly. I also consider a 
challenge that has special resonance in the animal ethics context: cross-species comparison of quality 
of life. 
 Quality of Life Across Conditions 
 One challenge that is magnifi ed in the animal health context involves the commensurability of 
quality-of-life measures across conditions. Some argue that it is diffi cult to compare the quality of 
life impacts of different medical conditions, such as limited mobility and chronic pain. It may be even 
harder to compare quality of life across different animals or animal species. 
 One possibility, if we use the questionnaire approach, is to ask humans these questions on behalf 
of the animals they are responsible for. This presents a variety of problems. First, humans who are 
responsible for animals may answer the questions in light of their own moral obligations to animals, 
obligations that may not track what is good for the animal overall. They may also select outcomes 
that are better for human caretakers even though worse for animals. For instance, humans may regard 
outcomes where an animal dies quickly as preferable to outcomes where an animal suffers in pain 
under their supervision, even if the animal would, in fact, be better off under the second option. Sec-
ond, moving from the deontic (what decision makers should do) to the axiological (what is valuable), 
proxy decision makers may, in general, judge outcomes to be different from the way that they seem 
from the fi rst-person perspective. For instance, people typically prefer pains to be in their own past 
rather than in their own future but may not exhibit the same time bias when they consider the pains 
that others experience ( Dorsey 2016 ). Third, human survey respondents may simply lack knowledge 
of what is actually in the interest of the animals whose lives they are describing. 
 One alternative would be to ascertain quality-of-life judgments by looking at the risks and trade-
offs animals actually accept—for instance, the risks they are willing to take in order to avoid pathogens 
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or to engage in play activities. We could regard animals’ actual behavior as revealing a preference 
for certain health states over others. However, some might worry that these revealed preferences are 
hard to interpret. It is diffi cult to tell whether a given decision refl ects a general preference or just a 
preference in a particular context. It is also challenging to know the extent to which we should try 
to determine what is good for animals by looking at what they actually do. For instance, the fact that 
dogs are willing to drink out of toilets might seem to suggest that they are willing to tolerate a high 
risk of illness in order to pursue their goal. But we might instead conclude that dogs, left to their own 
devices, are mistaken about what, in fact, is in their own interest. (They are like the person in John 
Stuart Mill’s famous example who is about to cross a rickety bridge he does not realize is rickety.) 
Similarly, some have argued that the fact that animals often hide when they notice a photographer 
suggests that they value privacy in the way that humans do and that hidden cameras would set back 
animal privacy interests just as they set back human ones (Pepper, unpublished). But their decision 
to hide might refl ect a mistake about the photographer’s purposes or about what the photographer 
is holding. This would push us toward an account of animal quality of life that is based on idealized 
choices (see  Heathwood 2006 ) or instead toward an account that is based on objective experiences 
or on measurements of hedonic states. 
 Particularly in the case of dogs and other social or altruistic animals, a further complication of a 
revealed preference approach is that not all an individual’s choices aim to improve that individual’s 
own quality of life. As an example, Amartya Sen argues that we should recognize that individuals 
sometimes make choices in full knowledge that those choices will worsen their own quality of life in 
order to honor certain commitments that they have ( Sen 1977 ). The soldier who throws himself on a 
grenade to save his platoon does not thereby reveal that he judges being pulverized to be an improve-
ment in his quality of life. Rather, he sacrifi ces his quality of life in order to honor his commitment 
to his fellow soldiers. This is true for animals as well: various choices animals might make could be 
understood not to aim at improving their quality of life but, rather, at honoring their commitments. 
These commitments can be to conspecifi cs, such as cases where animals sacrifi ce their lives for fel-
low pack members, but cross-species commitments are also possible ( Casal 2012 ). Another concern 
involves what Jon Elster, Sen, and Martha Nussbaum have dubbed “adaptive preferences” ( Teschl and 
Comim 2005 ). Animals may elect to do various things not because they contribute either to their 
own quality of life or to their commitments but, rather, because have been led to act in ways that 
serve the interests of others because of a mistaken sense of self-worth. 
 These concerns about purely desire-based approaches suggest the attractiveness of either hedonic 
or objective-list measures of animal quality of life that allow for comparisons across different condi-
tions. Given the complexity of many animals’ lives, I would argue that the same considerations that 
favor objective-list measures over purely hedonic ones—namely, that more matters to people than 
merely their psychological states—also apply to many animals. 
 One possibility is to use an externally observed hedonic account of quality of life to assess qual-
ity of life in animals that lack sophisticated self-awareness and long-term planning but to use an 
objective-list account (developed primarily through observation but also potentially through ques-
tionnaires) to assess quality of life among more mentally sophisticated animals. This distinction might 
track David DeGrazia’s suggestion that the interests of fi sh, amphibians, reptiles, and birds be assigned 
different, and lower, priority than the interests of other sentient animals ( DeGrazia 1996 ). On this 
view, some animals are capable of having a rich quality of life that goes beyond purely hedonic reac-
tions while others are not. 
 Quality of Life and Rights 
 Another challenge involves tensions between the utilitarian bent of most cost-effectiveness approaches 
and respect for individual rights. The 1991 Oregon Medicaid proposal, which set priorities strictly on 
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the basis of cost-effectiveness, was criticized for providing cost-effective but low-urgency interven-
tions, such as tooth capping, in preference to urgent but costly interventions such as appendectomies 
( Hadorn 1991 ). This objection involves what philosophers call the  aggregation problem—whether 
many minor burdens can be aggregated to outweigh a major burden. A related objection, termed 
the  fair chances/best outcomes problem, questions the exclusion of individuals who are unlikely to ben-
efi t, and a third, termed the  separate spheres/indirect benefi ts problem, contends that cost-effectiveness 
approaches give excessive weight to whether individuals who receive interventions will, in turn, 
produce other benefi ts for society ( Daniels 1993 ). 
 Many have suggested that utilitarian reasoning is distinctively appropriate when only animal 
interests are at issue ( McMahan 2002 ;  Nozick 1983 ). 2 Jeff McMahan effectively summarizes this view 
when he states that the “morality of respect,” which includes nonconsequentialist rights, applies to 
persons, but the “morality of interests,” which does not, applies to sentient animals ( McMahan 2002 ). 
If this is correct, cost-effectiveness methodologies might face fewer ethical headwinds when used to 
set priorities in animal health than they do in human health. It might be appropriate to, for instance, 
prevent many pigs from suffering painful bruises than to prevent a single pig from suffering very 
severe pain, even if it is inappropriate to make similar calculations where the lives of beings who fall 
within the morality of respect are at issue. It may also be appropriate to invest no resources at all in 
curing certain very rare animal diseases if those resources could instead be used to cure much more 
common diseases. In fact, even more radical utilitarian decisions that are widely agreed to be inap-
propriate in human health might be appropriate where animals are concerned, such as killing some 
animals in order to prevent a disease from spreading to many more. 
 McMahan’s view is well argued for and seems normatively plausible. If adopted, it would broaden 
the scope of permissible use of cost-effectiveness measures in animal health. However, others suggest 
that animals should be accorded deontological rights rather than being regarded as mere subjects 
of interests ( Regan 1985 ) or that “it’s not in general permissible to cause serious pain and injury to 
one morally signifi cant entity,” including an animal, “in order to benefi t others” ( Harman 2011 ). If 
animals fall within what might be termed the morality of respect, then rights-based concerns about 
the use of cost-effectiveness criteria to set priorities have more traction. A rights-based view also 
coheres with some of our practices regarding animals—in particular, the view in animal research that 
prioritizes refi ning research over reducing number of animals used on the basis that “the experience 
of an individual animal is paramount to the number of animals, and that additional suffering for the 
individual in exchange for a reduced total number of animals is not acceptable” ( Boo et al. 2005 ; 
see also  Ringblom 2016 ). This echoes the deontological view in human bioethics that recommends 
saving one person from death over saving many from minor pain. 
 However, many uses of cost-effectiveness criteria do not confl ict with conventionally recognized 
rights, because they move resources toward more cost-effective uses without violating any rights 
( Ord 2013 ). In order to resist these uses of cost-effectiveness criteria, one would have to assign moral 
weight to much more controversial rights claims, such as the “rule of rescue,” which recommends 
favoring identifi able lives over statistical lives or the view that numbers should not count when aid 
is being provided (see  Persad 2019 b). 
 An intermediate possibility is also interesting. On this view, the appropriateness of utilitarian 
reasoning in animal health would depend on the relevant animals’ capacities and social organiza-
tion: this suggestion builds on Judith Thomson’s speculation that act-utilitarianism is appropriate 
for eusocial animals but inappropriate for humans ( Thomson 1990 ). Utilitarianism might similarly 
be inappropriate for animals who are relevantly similar to humans but appropriate for social animals. 
By this logic, we might use a highly nonconsequentialist ethical theory for balancing the interests 
of animals that are solitary and typically competitive with conspecifi cs, such as tigers, in one way; a 
moderately nonconsequentialist theory for balancing the interests of animals who (like humans) are 
limited altruists in another way; and a utilitarian theory for balancing the interests of eusocial animals 
15031-3373d-1pass-r02.indd   107 10/20/2019   12:09:45 PM
Govind Persad
108
like bees. While this way of developing Thomson’s view is interesting, it has two clear limitations. 
One is that it may base moral obligations and permissions too closely on the natural abilities of spe-
cifi c creatures: that tigers may sometimes attack other tigers in nature does not entail that we should 
regard their interests as highly separate from a moral point of view. Another is that it does not address 
the question of how to handle trade-offs between the interests of animals from different species. 
 Quality of Life and Individual Differences 
 Cost-effectiveness approaches have been criticized for disadvantaging individuals who, because of 
comorbidities, can gain less quality or quantity of life from treatment. As an example, some cost-
effectiveness approaches to priority setting would assign lower priority for curing the cancer of 
someone who is blind, because the future life they gain from the treatment will be lower in quality 
due to their disability. This outcome has been criticized for being unjust and for further disadvantag-
ing the already disadvantaged ( Menzel et al. 1999 ; see also  Persad 2019 a). Another example is that 
most cost-effectiveness approaches will also assign lower priority to curing an illness for someone 
who cannot live for many more years, as opposed to someone who can live for many more years. 
John Harris and others have argued that this approach unfairly ignores the equal moral worth of each 
individual ( Harris 1987 ). 
 The frequently held view that extending animals’ lives matters much less from a moral point of 
view than does improving their quality of life would simplify the latter problem. If additional life-
years are assigned little or no value but quality of life has very high value, then animals who can 
potentially live for a longer time if they receive health benefi ts will receive little additional prior-
ity. However, the view that additional life counts for nothing seems implausible: we are willing to 
perform painful surgeries on some animals rather than painlessly euthanizing them, and we do so, in 
part, because we regard quantity, not only quality, of life as valuable for animals. Elizabeth  Harman 
(2011 ) illustrates this through a case of a young cat undergoing surgery (see also  DeGrazia 2016 ). 
Nonetheless, even though quantity of life in animals seems to count for something, it is plausible 
that quantity of life counts for less where animals are concerned. This suggests, for animals, replacing 
the standard way of calculating the QALY with a different function in which quantity is reduced in 
importance. 
 The problem of fairness to individuals with different capacities, in contrast, remains similarly 
urgent in the animal health context, and perhaps even more urgent given the differences between 
species. Imagine that wild turkeys have a better quality of life than chickens but the same moral sta-
tus. Should we be more interested in extending the life of the animal that starts out having a greater 
quality of life, or should we treat animals of equal moral status equally even if they differ in capacity? 
(Differences in moral status form a different, and potentially orthogonal, basis for prioritizing some 
animals over others.) The answer to this question depends on whether there is a way of compar-
ing quality of life across species, a question I take up in the next section. But similar questions can 
arise even regarding intraspecies decision making—should we assign lower priority to extending the 
life of a permanently blind horse than a healthy one? Again, the answer to these questions seems 
to depend in part on whether we regard animals as being within the morality of respect or instead 
within a morality of interests. 
 Quality of Life Across Species 
 Priority setting for animal health can be done with a wider or a narrower focus. Narrow priority 
setting would determine which interventions are of highest priority for a specifi c, homogeneous 
population—for instance, which chicken coop designs are most cost-effective at improving chickens’ 
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quality of life. Broader priority setting would attempt to set priorities among wider groups, including 
multiple species—for instance, to determine which alignment for a train line through a green space 
would least reduce the quality of life of the animals living in the green space or what treatment for 
animal disease should be the highest priority for a laboratory that is researching many animal diseases. 
 Wide priority setting in animal health presents the problem of  cross-species comparisons . For instance, 
the green space example might involve considering how various harms caused by pollution or noise 
affect the quality of life of deer, marmots, bears, and migratory birds. More challenging, they might 
also involve comparing the relative importance of a given change in quality of life for one type of 
animal to the importance of that change for other animals. We typically assume that all humans’ qual-
ity of life interests are given the same moral weight when setting priorities using cost-effectiveness 
considerations ( Drummond and Sorenson 2009 ). But this conclusion is much less obvious when 
we are making cross-species comparisons. It might seem mistaken, for instance, to assign the same 
weight to the loss in quality of life that a salamander would experience as to the loss that a bear or 
wolf would experience. However, determining what weight to assign to each individual’s experi-
ences is challenging. There is no obvious time trade-off or standard gamble—or revealed preference 
analogue of these—that would compare whether it is better to be a wolf or a salamander. Wolves 
and salamanders do not face situations where they could become members of the other species. Nor 
are there “competent judges,” in John Stuart Mill’s terms (see  Brownlee 2016 ) who have lived both 
sorts of lives and could recommend which is better. 
 One response to the challenge of cross-species quality of life comparisons would be to retreat to 
an approach that offers only a partial ordering of priorities ( Ruger 2004 ): on this approach, cost-
effectiveness could be used to set priorities within species but not between species. David DeGrazia 
seems to favor such a view in his comments on the potential incommensurability of human and 
animal quality of life: 
 [Consider the assumption] that there is a sort of objective super-scale of prudential value, 
by reference to which one can evaluate the well-being of every actual and possible crea-
ture in virtue of its realization of the items enumerated on the massive (infi nite?) list. One 
might fi nd, as I do, the sheer grandiosity of such a conception a reason to doubt it. It seems 
to require a standpoint of prudential evaluation that is so impartial as to be God-like, or 
Platonic Form-like. . . . Despite lacking a decisive argument against the idea of an objective 
super-scale of prudential value, I suspect that this idea is misguided. It seems to me more 
plausible that assessments of prudential value must be relativized to the sort of creature in 
question and, in particular, to the native capacities of such creatures. 
 ( DeGrazia 2016 : 514-515) 
 However, the frequent skepticism in animal ethics about the fundamental moral weight of biological 
categories such as species membership ( McMahan 2002 ), and the potential value of an approach that 
assists decisionmakers who must compare the interests of different types of animals—ranging from 
veterinarians conducting triage and allocating limited treatments to policymakers setting priorities 
for animal health investments—indicates the value of a quality-of-life measure that crosses species 
boundaries. 
 What are the candidates for such a measure? As discussed earlier, the most natural ones are 
objective-list measures (either conducted by proxies or external assessment) and hedonic measures. 
As DeGrazia observes, of course, there are challenges in constructing an objective list measure. To riff 
on Mill, is it better to be a “salamander satisfi ed” or a “pig dissatisfi ed”? Even if we can determine, for 
example, that it is worse to be a pig in chronic pain than a pig with a hearing impairment, it is hard 
to identify the list of capacities that would tell us whether it is better to be a pig in chronic pain or 
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a healthy salamander. Notwithstanding these challenges, however, generating broader quality-of-life 
assessments seems possible. As McMahan observes, 
 [i]t might be suggested that individuals should be ranked hierarchically according to their 
level of psychological capacity or potential. On this view, all individuals with equivalent 
capacities or potential would count as higher forms of being than individuals with lower 
capacities and potential. This offers a way of articulating our sense that it is better to be a 
person than to be a dog. Persons are higher forms of being: their capacities are higher, the 
range of good accessible to them is higher, and in general their lives are better, or more 
valuable, or more worth living, than those of dogs 
 ( McMahan 2002 : 160). 
 DeGrazia, in discussing similar cases, expresses skepticism about the specifi c judgment that dogs are 
better off than human persons, although he does not categorically reject the view. He observes that 
“[n]o human being has had, for example, the experience of walking through the neighborhood 
and recognizing the unmistakable scents of dozens of familiar people and dogs. No human being 
has experienced the magnifi cent depths of auditory experience that dogs experience every day” 
( DeGrazia 1996 : 4). As a factual matter, DeGrazia is correct. But it seems plausible that the value of 
complex psychological experiences, such as composing a symphony or designing a fragrance out-
weighs the value of the sensory experience of smelling many fragrances or hearing many sounds, 
particularly from an objective-list rather than purely hedonistic perspective. (Think of Beethoven 
even after his deafness.) DeGrazia himself grants that he lacks a decisive argument against “an objec-
tive super-scale of prudential value” ( DeGrazia 1996 : 4), and the use of such a scale has the advantage 
that it avoids regarding species membership itself as objectively signifi cant. 3
 In any event, DeGrazia’s relativization approach appears too strong—it forecloses the possibility 
of plausible partial orderings across different types of creatures. Even if one agrees with DeGrazia 
that the experience of animals like dogs, dolphins, and bats is so different from humans’ experience 
of living their lives as to be incommensurable, there may be some species of animals whose life 
experiences are “strictly dominated” (to use technical language) by the experiences of other, similar 
animals—their capacities are close to a proper subset of other animals’ capacities. An example might 
be dolphin species that are less intelligent than the bottlenose dolphin but have the same sensory 
capacities; more broadly, we might be able to compare very different species of birds and conclude 
that some have richer lives than others. We might also be able to compare different developmental 
stages or morphological forms of the same organism: even though tadpoles have some capacities that 
frogs lack, it seems plausible that frogs overall have a richer set of experiences. 
 A different way of approaching the problem of cross-species comparisons is to focus on commu-
nities of animals or on ecosystems, rather than on the effects of policy decisions or other forces on 
individual animals. This approach would combine the interests of all animal denizens of the park (as 
well as potentially other living beings, and even the interests of natural artifacts insofar as they can be 
said to have interests), and would then assess the impact of the choice on the interests of the ecosystem 
as a whole. This approach would clearly reject the position taken by thinkers such as Regan and Har-
man, who regard each individual as separate and worthy of respect, in favor of a more holistic evalua-
tion of the ecosystem’s good. However, it would also differ from the position that McMahan defends, 
which regards the quality of life that different animals enjoy as commensurable. Instead of comparing 
different animals’ quality of life, it would subsume their experiences under a larger unit of evaluation. 
 Last, reasoning about moral status may pull in a different direction from reasoning about qual-
ity of life. We might conclude, based on an objective list of capacities such as complex planning, 
complexity, and community living, that it is preferable to be a pig than to be a salamander, and even 
that it is better to be a pig in chronic pain than to be a salamander in good health. (This is what we 
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conclude about the comparison between humans and salamanders.) Yet we may conclude that it is 
more morally urgent to relieve the pain of a pig than that of a salamander, even though it may be far 
worse to be a salamander in ill health than a pig in ill health. DeGrazia discusses, although does not 
explicitly endorse, an “unequal consideration” account of moral status that incorporates not only the 
capacities an animal has but also what sort of considerability the animal possesses ( DeGrazia 2008 ). 
Cost-effectiveness approaches could operationalize DeGrazia’s unequal consideration account by 
differentially weighting quality-adjusted life-years or similar metrics according to the moral status of 
the animal whose health is at issue. 
 Another factor that could be relevant, and could pull in a different direction from quality of life, 
is the special obligations that may be owed to certain animals or groups of animals. Recent work by 
Sue Donaldson and Will Kymlicka makes the case that domesticated animals are owed obligations 
of co-citizenship, whereas wild animals should instead be afforded sovereignty, and “liminal” animals, 
which live in human communities but are not domesticated, should be granted a “denizenship” 
status that differs from citizenship ( Donaldson and Kymlicka 2011 ). Importantly, Donaldson and 
Kymlicka’s approach does not base special obligations on animals’ capacities or quality of life—as an 
example, rabbits could be owed obligations of co-citizenship, sovereignty, or denizenship depending 
on whether they are pet rabbits, wild rabbits, or rabbits living in proximity to humans. Ultimately, 
quality of life is unlikely to be the only factor in cross-species priority setting and can be outweighed 
by considerations of moral status or special obligation. 
 Operationalizing Cost-Effectiveness to Set Priorities in Animal Health 
 Perhaps the simplest and least controversial strategy for expanding the use of cost-effectiveness in 
animal health is to use quality of life measures to create species-specifi c QALY analogues. One such 
example could be, for instance, QADYs (quality-adjusted dog years). This approach would not take 
on the challenge of making cross-species comparisons but could be used to set priorities for research 
into medical interventions that might benefi t dogs or to decide which dogs should receive a scarce 
medical resource in a triage situation. 
 A more controversial approach would be to try to fi nd some way of commensurating the species-
specifi c metrics into a unifi ed metric. We might call this the QAALY (quality-adjusted animal life-
year). 4 Using a QAALY distributive metric would allow priorities to be set for interventions that 
affect many different species of animal—for instance, whether to prioritize a given treatment for pigs 
over another one for chickens. 
 Even without a QAALY distributive metric in place, it may still be possible to make some priority-
setting decisions in light of species-specifi c quality-of-life measures. This could involve a process 
of weighing, specifying, and balancing different considerations against one another, just as is done 
when QALYs are being compared to non-QALY criteria in human health contexts. It could also 
involve the use of an extended cost-effectiveness analysis that compares costs to both quality-of-life 
outcomes and other types of outcomes (see  Garrison et al. 2017 ). 
 One challenging issue for both QAALYs and the species-specifi c approach involves potential 
confl icts between human and animal interests. Would we ever be justifi ed in preferring to realize 
some quantity of animal QALYs rather than a smaller quantity of QALYs for humans? This may 
seem intolerable where life and death for humans are considered and may favor a “lexical priority” 
approach in which the lives of humans are incomparably more important than quality improve-
ments in the lives of animals, no matter how many animals benefi t (see  Zamir 2006 : n.3). On the 
other hand, commonsense practice does allow some trade-offs between human and animal QALYs 
where human life is not directly at stake, particularly when the amount of human suffering at issue 
is small—for instance, we might accept a slightly more painful treatment for humans if it can be 
produced in a way that causes less animal pain ( Zamir 2006 ). 
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 When combined with the common view that some cases of human pain are more morally signifi -
cant than some risks to human life—which underlies, for instance, the permissibility of risky surgery 
to cure chronic pain—this could present a problem of intransitivity: a suffi cient quantity of human 
pain can be more important than a human life, but no quantity of animal pain could justify sacrifi c-
ing a human life, yet some quantity of animal pain could outweigh a quantity of human pain. Similar 
intransitivities are familiar elsewhere in bioethics ( Kamm 1985 ). 
 Conclusion 
 I have argued in favor of greater use of cost-effectiveness criteria to set priorities in animal health. 
I close with a practical note of caution: a familiar challenge to priority setting discussed by Norman 
Daniels retains force and relevance in the animal ethics context. Daniels argues that it is diffi cult to 
justify comprehensively setting priorities for medical interventions using cost-effectiveness calcula-
tions within a health care system, like that in the US, where the savings realized by reducing the 
provision of interventions with poor cost-effectiveness will not necessarily go toward the provision 
of more cost-effective interventions, which would lead to net improvements in health but might 
instead go toward nonhealth programs ( Daniels 1986 ). Some might similarly worry that priority-
setting efforts will lead to less money being spent on worthy goals in animal health, and redirected 
toward other, less important, aims. For priority setting that cuts spending on animal health, rather 
than reallocating it, to be justifi ed, the alternative spending proposal must be more important. 
 Notwithstanding Daniels’s concerns, incorporating cost-effectiveness considerations into choices 
regarding animal health could lead to substantial improvements in animal health. Many of the ethical 
constraints that count against the use of cost-effectiveness to set priorities do not apply, or at least 
not so clearly, to their use in setting priorities among animals and with regard to animal health issues. 
Yet there is little current use of cost-effectiveness to set priorities in animal health—much less than 
in human health. This perhaps stems from the fact that animal health is highly disunifi ed, with care 
for wild animals, farm animals, pets, and laboratory animals governed by different rules and poli-
cies. There is no National Health Service or Medicaid for animals, or National Institutes of Health 
to organize research into animal health. Yet we spend substantial sums of money on animal health 
despite this and do so in a disorganized way. As an example, federal law in the US requires that pets 
be included in emergency planning ( Leonard and Scammon 2007 ). Many millions of dollars are 
spent on animal health. Even if some of this spending has the goal of promoting human interests, 
some of it is clearly spent on animals themselves. By considering cost-effectiveness, we can use that 
money to make animals’ lives go better. As Ord observes in human health contexts, “[i]gnoring cost-
effectiveness . . . does not mean losing 10 percent or 20 percent of the potential value that a health 
budget could have achieved, but can easily mean losing 99 percent or more” ( Ord 2013 : 5). He goes 
on to state that “[t]he main effect of understanding the moral imperative toward cost-effectiveness is 
spending our budgets so as to produce greater health benefi ts, saving many more lives and preventing 
or treating more disabling conditions” ( Ord 2013 : 7). This is true for humans, but it is at least as true 
for animals. It is time to consider cost-effectiveness in animal health. 
 Notes 
 1.  I use  animal as shorthand throughout for “nonhuman animal.” 
 2.  Elizabeth Harman presents but rejects the view that “[o]ne might try to develop a view on which the kinds 
of agent-relative constraints that apply to persons do not apply to animals or animal stages. On such a view, 
it would be permissible to harm one animal or animal stage in order to provide positive benefi ts to a distinct 
entity,” without discussing McMahan’s view on the morality of respect, even though she discusses other parts 
of McMahan’s book (Harman 2011). 
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 3.  “But while it seems right that a condition must be evaluated by comparison with what is possible given a 
certain set of psychological capacities, it seems a mistake to suppose that the relevant capacities are those 
typical of the members of the individual’s own biological species” (McMahan 2002: 325). 
 4.  Pesie similarly suggests that “[t]his research explores the possibilities to develop an Animal Health Utility 
Index (AHUI), by which reductions in QoL can be quantifi ed to indicate the ‘Animal Disease Burden’ 
(ADB) (i.e. the change in QoL during a time period), comparable to the quantifi cation of QALYs in 
humans” (Pesie 2012: note 4). 
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